Forbes William P — SEC insider filings
SEC reporting owner CIK 1314760. 39 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2021-02-03 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 4 filings — 85,000 shares, $139,895 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 99.
- Largest priced transaction: purchase of 50,000 shares @ $0.94 ($46,995) in HERON THERAPEUTICS, INC. /DE/, filed 2023-11-20.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | EVP, Chief Development Officer | 26 | 2 legs · 75,000 sh · $74,245 | — | 60 |
| Beyond Air, Inc. (XAIR) | Director | 9 | 2 legs · 10,000 sh · $65,650 | — | 35 |
| Trevi Therapeutics, Inc. (TRVI) | Chief Development Officer | 4 | — | — | 4 |
Insider filings — Forbes William P
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,770 · Tax withholding (F): 3,349 @ $0.28 · Option exercise (M): 11,695 · Tax withholding (F): 3,327 @ $0.28 · Option exercise (M): 11,770 (derivative) @ $0 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2026-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Tax withholding (F): 1,102 @ $0.36 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-08-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,769 · Tax withholding (F): 3,348 @ $0.50 · Option exercise (M): 11,694 · Tax withholding (F): 3,326 @ $0.50 · Option exercise (M): 11,769 (derivative) @ $0 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2026-07-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Tax withholding (F): 1,101 @ $0.47 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,770 · Option exercise (M): 11,694 (derivative) @ $0 · Option exercise (M): 11,770 (derivative) @ $0 | EDGAR |
| 2026-04-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 188,315 (derivative) @ $0 · Grant/award (A): 188,314 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2025-11-06 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · Disposition to issuer (D): 400 (derivative) · Grant/award (A): 400 (derivative) · Disposition to issuer (D): 1,250 (derivative) · Grant/award (A): 1,250 (derivative) · +10 more | EDGAR |
| 2025-11-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-08-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,695 · Option exercise (M): 11,695 (derivative) @ $0 | EDGAR |
| 2025-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 11,694 · Option exercise (M): 11,694 (derivative) @ $0 | EDGAR |
| 2025-04-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 374,220 (derivative) @ $0 · Grant/award (A): 187,110 (derivative) @ $0 | EDGAR |
| 2025-01-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Beyond Air, Inc. (XAIR) | Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Grant/award (A): 8,000 (derivative) · Disposition to issuer (D): 25,000 (derivative) · Grant/award (A): 25,000 (derivative) · +8 more | EDGAR |
| 2024-10-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-07-22 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,875 · Option exercise (M): 3,875 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 12,500 · Option exercise (M): 12,500 (derivative) @ $0 | EDGAR |
| 2024-04-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Option exercise (M): 3,874 · Option exercise (M): 3,874 (derivative) @ $0 | EDGAR |
| 2024-03-21 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2024-01-19 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Grant/award (A): 371,935 (derivative) @ $0 · Grant/award (A): 61,989 (derivative) @ $0 | EDGAR |
| 2023-11-21 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Purchase (P): 25,000 @ $1.09 | EDGAR |
| 2023-11-20 | 4 | HERON THERAPEUTICS, INC. /DE/ (HRTX) | Purchase (P): 50,000 @ $0.94 | EDGAR |
| 2023-04-03 | 4 | Beyond Air, Inc. (XAIR) | Purchase (P): 5,000 @ $6.67 | EDGAR |
| 2023-03-31 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2023-03-20 | 4 | Beyond Air, Inc. (XAIR) | Purchase (P): 5,000 @ $6.46 | EDGAR |
| 2022-07-01 | 4/A | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 137,500 (derivative) @ $0 | EDGAR |
| 2022-07-01 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2022-03-07 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2022-02-15 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 137,500 (derivative) @ $0 | EDGAR |
| 2021-03-08 | 4 | Beyond Air, Inc. (XAIR) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-02-03 | 4 | Trevi Therapeutics, Inc. (TRVI) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1314760 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs